PROPEL TECHNOLOGY SERVICES, INC. – Trademark Portfolio

Entity Type: 03

PROPEL TECHNOLOGY SERVICES, INC. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. Currently, 4 trademarks are registered. Notable registered marks include PHLEBIO and PHLEBNET. The owner is based in Ontario, CA.

337 N Vineyard Blvd, Suite 400

Ontario, CA 91764

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PHLEBNET
PHLEBNET
Registered 2025
PHLEBNET
PHLEBNET
Registered 2025
PHLEBIO
PHLEBIO
Registered 2019
PHLEBIO
PHLEBIO
Registered 2019

Trademark Classifications

PROPEL TECHNOLOGY SERVICES, INC.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (4 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does PROPEL TECHNOLOGY SERVICES, INC. have?

PROPEL TECHNOLOGY SERVICES, INC. has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does PROPEL TECHNOLOGY SERVICES, INC. file in?

PROPEL TECHNOLOGY SERVICES, INC. files trademarks across 1 Nice Classification class. The most active classes are Class 42 (Computer & Scientific). Class 42 covers scientific and technological services; industrial analysis and research services.

What are PROPEL TECHNOLOGY SERVICES, INC.'s most well-known trademarks?

PROPEL TECHNOLOGY SERVICES, INC.'s registered trademark portfolio includes well-known marks such as PHLEBIO and PHLEBNET. These are among 4 currently registered trademarks in the portfolio.

What is PROPEL TECHNOLOGY SERVICES, INC.'s trademark registration success rate?

PROPEL TECHNOLOGY SERVICES, INC. has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.